New medication, Istradefylline, gets approved for Parkinson’s disease

New medication, Istradefylline, gets approved for Parkinson’s disease
New medication, Istradefylline, gets approved for Parkinson’s disease On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA webinar.) The medication, which will ... read more
Source: American Parkinson Disease AssociationPublished on 2019-09-04By Stephanie Paul